1800 244 735

Helpline (02) 9874 9777

An Open Letter to the Australian Huntington’s Community

On 23 March 2021, the news began rolling out across the world that Roche would stop administering the treatments or placebos to patients in the GENERATION HD1 trial. More information will become available in the next weeks and months. The news from the study data analysis this week, however, suggests that in the current GENERATION HD1 trial, there is not enough benefit from the drug to support continued treatment. Roche is clear that the reason for stopping the drug does not relate to new concerns about the safety of the treatment. Importantly, Roche has not said they are stopping its HD program overall. The coming months may reveal Roche’s plans for HD following GENERATION HD1.

Since the news from Roche came out, Australian clinicians, state organisation leaders, and Huntington’s researchers have been meeting on teleconferences to discuss what this means for the Australian Huntington’s disease community. We share your disappointment at the sudden news that the treatment aspect of the trial has been stopped. But we also remain optimistic about the future.

 

What does this news from Roche mean for the HD community?

The Roche trial will leave us all with many valuable learnings to apply in future trials. And many more very promising treatments are being explored in research studies. For example, here in Australia, we have two very important trials underway across five sites in four cities: Brisbane, Sydney, Perth and Melbourne. These trials are sponsored by Wave Life Sciences, a company based in Boston, USA. Wave is getting ready to start a third trial, which will also roll out in Australia. Outside of Australia, at least 10 more HD trials are underway or getting started, all with significant financial investment. We have a lot more treatments to try, and research will continue until treatments are found.

We are very grateful to those people who have volunteered for our HD clinical trials so far, and to the many of you who have participated in research. Australia is a key research hub, recognised internationally for our work in HD. We need the Australian HD community to continue giving their time and energy, so that together we can move closer to treatments that make a real difference for families with HD. Everyone can help. This includes people with HD, their family members, clinicians and support workers of all kinds, and our state organisations.

Across Australia, we are committed to making things better for families with HD, with better treatments, care, and support. Despite the very disappointing news this week, we remain full of energy, and we will continue to work as a united Australian community to do whatever is necessary so that every person who is affected by HD can live their best life.

 

Written collectively by the CEOs of Australian Huntington’s Associations with leading national HD clinicians and researchers

Huntington’s NSW ACT, Huntington’s WA, Huntingtons Queensland, Huntington’s SA & NT, Huntington’s Tasmania, Huntington’s Victoria

 

Clinical trials: your questions answered

Latest News and Stories

donate scene cartoon

We are recruiting – NDIS Support Coordinator

Published date: 3 April, 2023

Huntington’s NSW ACT provides services and advocacy to improve the lives of Australians impacted by Huntington’s disease and other disabilities under the National Disability Insurance Scheme (NDIS). Under the banner and leadership of Huntington’s NSW ACT, this role works with the Huntington’s Queensland team, to provide support to people with Huntington’s disease (HD) in Queensland, to activate and manage their NDIS plans and engage with a range of mainstream and disability providers to optimise outcomes and achieve their NDIS plan goals.

An update on all things Huntington’s Australia

Published date: 29 March, 2023

As a valued member of the HD community, we’d like to keep you up to date with Huntington’s Australia (HA) developments. The merger implementation is in full swing and just about everyone is getting involved in some way, shape or form. All staff are in the process of having discussions with our CEO, Lenni, and our HR Specialist, Lyn, about transitioning into the new HA organisation. We are still expecting that most of the staff employed by State Associations will transfer to HA. In addition to our CEO, we now also have another two of the senior management team selected, and both are starting this month - Leah Atkinson as the Head of Finance and Corporate Services and Basil Mabuza as the Head of Community Programs and Services.
HD news image

HD News Autumn 2023

Published date: 23 March, 2023

Download your copy of HD News Autumn edition by clicking on the link. Some of the highlights in this edition are: Introduction to our counselling service Youth education scholarships Appointment of a CEO for Huntington’s Australia We hope that you enjoy this edition of HD News. If you have any feedback or would like to get in ... Read more

Ailsa’s Legacy – HD Education Scholarship

Published date: 17 March, 2023

We are excited to announce that applications for the 2023 Ailsa’s Legacy Youth Scholarships are now open and invite all children and young people in our HD community needing assistance to start, continue, or return to education in 2023 to apply. We have a number of individual grants available this year of up to $2000 each for children and young people living with an HD affected parent or carer. These grants can be spent on anything that makes accessing education easier and more likely such as course or school fees, uniforms and shoes, computers, IT and software, school camps, school sports, extra tuition, extracurricular activities, transport, accommodation, and more.
lady doing an announcement

NAA pre-budget submission for the 2023-24 Federal Budget

Published date: 6 March, 2023

The Neurological Alliance Australia * (NAA) is pleased to provide a pre-Budget submission to the Australian Government for the 2023-2024 Budget. This submission focusses on four key areas that will impact people affected by the conditions represented by the members of the NAA.

HD Heroes book release

Published date: 6 March, 2023

Huntington’s Disease Heroes includes stories from a scientist who switched from cancer research to studying Huntington’s after finding out her mother had tested positive for the disease, a young man whose biggest fear was testing gene negative and not inheriting the disease, and a woman who grew up in survival mode, unable to express her grief. We learn about the ways their lives are better off because of the hardships they have faced. By sharing these intimate parts of their lives, they are taking away the fear and stigma of living with Huntington’s in their families. They are giving a voice to this unheard rare disease community and empowering others to speak up.